Stockscreener 앱 받기
17.38
1.86%
-0.33
시간 외 거래:
17.06
-0.32
-1.84%
Arcutis Biotherapeutics Inc 주식(ARQT)의 최신 뉴스
Published on: 2025-09-20 11:38:58 - khodrobank.com
Triumph Capital Management Purchases Shares of 29,244 Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Stock Analysis: Is Arcutis Biotherapeutics Inc stock good for income investors2025 Trading Volume Trends & Weekly Chart Analysis and Guides - khodrobank.com
Analyst Upgrade: What is Arcutis Biotherapeutics Inc. s 5 year growth outlookTrade Entry Summary & Community Driven Trade Alerts - khodrobank.com
EPS Watch: Can Viavi Solutions Inc maintain its current growth rateEarnings Risk Report & Weekly High Conviction Trade Ideas - khodrobank.com
Breakout Move: Can Arcutis Biotherapeutics Inc sustain earnings growthJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - khodrobank.com
Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Up 4.5%Time to Buy? - MarketBeat
Take Profit: What are the future prospects of Arcutis Biotherapeutics IncQuarterly Risk Review & Stepwise Trade Execution Plans - خودرو بانک
Anti-Aging Market Surges as $101M Competition Drives Demographic Revolution - Baystreet.ca
Income Plays: Will FBLA face regulatory challengesRecession Risk & Reliable Intraday Trade Alerts - خودرو بانک
Invst LLC Makes New Investment in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Market Review: Is ProShares Trust ProShares UltraPro Short S&P500 a good ESG investmentJuly 2025 WrapUp & Expert-Curated Trade Recommendations - خودرو بانک
CEO Change: Can NanoViricides Inc continue delivering strong returnsWeekly Risk Summary & Safe Entry Zone Tips - خودرو بانک
Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress - The Manila Times
Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress | Dow Theory Letters - FinancialContent
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award - GlobeNewswire
Fred Alger Management LLC Invests $568,000 in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
FOMO Trade: Does Arcutis Biotherapeutics Inc stock reflect fundamentals2025 Sector Review & Low Drawdown Trading Techniques - خودرو بانک
Arcutis Biotherapeutics’ ZORYVE Wins 2025 Allure Best of Beauty Breakthrough Award for Innovation in Dermatology - Quiver Quantitative
Aug Big Picture: Can Arcutis Biotherapeutics Inc stock outperform in a bear market2025 Dividend Review & AI Enhanced Trading Signals - khodrobank.com
Arcutis Biotherapeutics, Inc. (ARQT) Eyes Pediatric Expansion for ZORYVE Cream - MSN
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Todd Watanabe Sells 9,625 Shares - MarketBeat
Aug Reactions: Will Arcutis Biotherapeutics Inc. benefit from current market trendsMarket Performance Summary & Weekly Top Stock Performers List - khodrobank.com
Chipmakers Recap: Can Arcutis Biotherapeutics Inc sustain earnings growthJuly 2025 Reactions & Reliable Momentum Entry Alerts - khodrobank.com
What are analysts price targets for Arcutis Biotherapeutics Inc2025 Retail Activity & Safe Swing Trade Setup Alerts - khodrobank.com
Fund Flows: What are analysts price targets for Arcutis Biotherapeutics IncQuarterly Investment Review & Daily Profit Maximizing Tips - خودرو بانک
Market Outlook: Is Arcutis Biotherapeutics Inc. forming a bullish divergence2025 Technical Overview & Consistent Income Trade Recommendations - خودرو بانک
Volume Recap: Is Arcutis Biotherapeutics Inc a good stock for dollar cost averagingMarket Performance Summary & Weekly High Momentum Picks - khodrobank.com
Published on: 2025-09-15 14:30:32 - خودرو بانک
Arcutis Biotherapeutics (NASDAQ:ARQT) Sets New 1-Year HighHere's Why - MarketBeat
What MACD signals say about Arcutis Biotherapeutics Inc.2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
Arcutis Biotherapeutics Inc. stock trend forecastPortfolio Value Report & Stock Portfolio Risk Control - newser.com
Measuring Arcutis Biotherapeutics Inc.’s beta against major indicesJuly 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Arcutis Biotherapeutics Inc. stock volume spike explainedTrade Signal Summary & Smart Swing Trading Alerts - newser.com
Using economic indicators to assess Arcutis Biotherapeutics Inc. potentialPortfolio Return Summary & Safe Entry Momentum Tips - newser.com
Is it time to cut losses on Arcutis Biotherapeutics Inc.2025 Earnings Impact & Consistent Return Investment Signals - newser.com
Scientech Research LLC Takes Position in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $583,860.80 in Stock - MarketBeat
22,082 Shares in Arcutis Biotherapeutics, Inc. $ARQT Bought by Ieq Capital LLC - MarketBeat
Arcutis Biotherapeutics CEO Watanabe sells $177k in shares By Investing.com - Investing.com South Africa
Arcutis Biotherapeutics CEO Watanabe sells $177k in shares - Investing.com
Arcutis Biotherapeutics Submits Supplemental New Drug Application to FDA For ZORYVE - MSN
Arcutis Biotherapeutics (ARQT) Surges 31% In Last Quarter - Yahoo Finance
Arcutis at H.C. Wainwright: Strategic Growth and Pipeline Development - Investing.com
1.43%
0.09%
자본화:
|
볼륨(24시간):